2018
Trust in neuroendocrine tumors: The importance of communication in rare and chronic malignancies.
Mou E, Wittenberg T, Kunz P, Schapira L. Trust in neuroendocrine tumors: The importance of communication in rare and chronic malignancies. Journal Of Clinical Oncology 2018, 36: 75-75. DOI: 10.1200/jco.2018.36.7_suppl.75.Peer-Reviewed Original ResearchNeuroendocrine tumorsQuality of lifeChronic malignanciesMedical mistrustMedical community awarenessSupport group participantsPhysician-patient communicationScreening compliancePhysician-patient relationshipRare malignancyTreatment adherenceUncommon cancerCancer surveillanceTherapy recommendationsPhysician communicationClinician expertiseMEDLINE searchSymptom recognitionRare naturePatientsMeSH headingsCommunity settingsAreas of concordanceRace discordanceMalignancy
2013
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas 2013, 42: 557-577. PMID: 23591432, PMCID: PMC4304762, DOI: 10.1097/mpa.0b013e31828e34a4.Peer-Reviewed Original ResearchConceptsNeuroendocrine tumorsConsensus guidelinesNorth American Neuroendocrine Tumor SocietyPhase 3 trialTreatment of patientsHeterogeneous clinical presentationPractice-changing outcomesClinical presentationNovel agentsAnatomic locationTumorsHeterogeneous groupDegree of aggressivenessTreatmentDiseaseConsensus tableGuidelinesRigorous evaluationEverolimusSunitinibPatientsMalignancyPhysiciansTrials